跳至主要内容
临床试验/NCT02961725
NCT02961725Unknown1 期

Umbilical Cord Mesenchymal Stem Cells for Treatment of Bronchopleural Fistula

The Second Affiliated Hospital of Fujian Medical University1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2016年4月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
10
试验地点
1
主要终点
closure of the fistula

研究概览

简要总结

Bronchopleural fistula (BF), an abnormal passage or communication between a bronchus and another part of the body, may develop when there are penetrating wounds of the thorax and after lung surgery. Without effective therapy, treatment of BF is a challenge, with a high rate of mortality and teratogenicity.

The investigators will conduct endoscopic injection of umbilical cord mesenchymal stem cells to fistula, observe the recovery of bronchopleural fistula and systemic reactions, to investigate the application of umbilical cord mesenchymal stem cells in the treatment of bronchopleural fistula.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosed with bronchopleural fistula by imaging or bronchoscopic examination
  • typical symptom of bronchopleural fistula, such as fever, cough, purulent sputum, weight loss...
  • patients present compromised conditions, who can only accept a conservative treatment.

排除标准

  • absolute contraindication of bronchoscopic examination and treatment
  • with previous treatment of cell therapy, including stem cells.

结局指标

主要结局

closure of the fistula

时间窗: 24 weeks

median time for fistula closure

次要结局

  • complication(1 year)

研究者

发起方
The Second Affiliated Hospital of Fujian Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验